Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

about

Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q53812090

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@en

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@nl

type

Item

label

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@en

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@nl

prefLabel

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@en

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@nl

P1476

Continuing EGFR-TKI treatment ...... nt non-small cell lung cancer.

@en

P2093

Dong Yu

http://www.w3.org/2001/XMLSchema#string

Huijuan Ni

http://www.w3.org/2001/XMLSchema#string

Huiwei Qi

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Qiong Hu

http://www.w3.org/2001/XMLSchema#string

Sen Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Drug penetration in solid tumours

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Carinal resection after induction bronchial arterial infusion for locally advanced non-small cell lung cancer.

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Combined modality therapy of gemcitabine and radiation.

Imaging of liver metastases: MRI.

Antimetabolite radiosensitizers.

P2888

s12032-015-0704-x

P304

256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-015-0704-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26496741

http://www.w3.org/2001/XMLSchema#string